Note: This data visualization was originally published in March 2017.
As of June 2019, an estimated 29 new nontraditional products1 with the potential to treat or prevent serious bacterial infections were in clinical development. Below is a snapshot of the current nontraditional products pipeline, based on publicly available information and informed by external experts. It is updated periodically, as products advance or are known to drop out of development. Because of periodic updates, endnote numbers may not be sequential. Please contact [email protected] with additions or updates.
Please contact [email protected] with additions or updates.